Literature DB >> 6625781

Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease.

R K Heaton, I Grant, A J McSweeny, K M Adams, T L Petty.   

Abstract

The Nocturnal Oxygen Therapy Trial (NOTT) showed previously that patients with hypoxemic chronic obstructive pulmonary disease (COPD) frequently suffered from neuropsychologic deficit and experienced disturbed mood, personality, and life quality. The present study has followed up 150 NOTT patients six months after they were randomized to continuous oxygen treatment (COT) or nocturnal oxygen treatment (NOT). Tested off oxygen, 42% showed modest neuropsychologic improvement after six months of therapy, and the rates for COT and NOT were comparable. A subsample (n = 37) was examined a third time, after 12 months of treatment. At this point patients receiving COT registered better neuropsychologic performance than those receiving NOT. Concurrently, the COT group began showing improved survival. Despite mild neuropsychologic improvement, patients reported little change in emotional status or life quality. It is concluded that prolonged oxygen treatment is associated with small but definite improvement in brain functioning among patients with hypoxemic COPD, and that COT might have some advantage over NOT in enhancing neuropsychologic functioning as well as survival.

Entities:  

Mesh:

Year:  1983        PMID: 6625781

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  39 in total

Review 1.  Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.

Authors:  Darcy D Marciniuk; Donna Goodridge; Paul Hernandez; Graeme Rocker; Meyer Balter; Pat Bailey; Gord Ford; Jean Bourbeau; Denis E O'Donnell; Francois Maltais; Richard A Mularski; Andrew J Cave; Irvin Mayers; Vicki Kennedy; Thomas K Oliver; Candice Brown
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

2.  The appropriate use of oxygen.

Authors:  S Lubin
Journal:  Can Fam Physician       Date:  1988-10       Impact factor: 3.275

Review 3.  Hypoxia, almitrine, and peripheral neuropathy.

Authors:  P Howard
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

4.  Two Eyes Are Better Than One-Binocular Summation of Dark Vision in Healthy Individuals and Patients with Chronic Respiratory Disease.

Authors:  Joakim Thylefors; Ulf Havelius
Journal:  Neuroophthalmology       Date:  2014-04-02

Review 5.  Oxygen therapy in chronic obstructive pulmonary disease.

Authors:  Victor Kim; Joshua O Benditt; Robert A Wise; Amir Sharafkhaneh
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 6.  Cognitive and psychological issues in emphysema.

Authors:  Elizabeth Kozora; Charles Emery; Robert M Kaplan; Fredrick S Wamboldt; Lening Zhang; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  COPD and cognitive impairment: the role of hypoxemia and oxygen therapy.

Authors:  Neeta Thakur; Paul D Blanc; Laura J Julian; Edward H Yelin; Patricia P Katz; Stephen Sidney; Carlos Iribarren; Mark D Eisner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07

8.  Individual-patient monitoring in clinical practice: are available health status surveys adequate?

Authors:  C A McHorney; A R Tarlov
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

9.  Alzheimer's disease, sleep apnea, and positive pressure therapy.

Authors:  Donald L Bliwise
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.598

Review 10.  Treatment of respiratory failure in COPD.

Authors:  Stephan Budweiser; Rudolf A Jörres; Michael Pfeifer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.